230 related articles for article (PubMed ID: 24706814)
1. Whole-exome sequencing reveals LRP5 mutations and canonical Wnt signaling associated with hepatic cystogenesis.
Cnossen WR; te Morsche RH; Hoischen A; Gilissen C; Chrispijn M; Venselaar H; Mehdi S; Bergmann C; Veltman JA; Drenth JP
Proc Natl Acad Sci U S A; 2014 Apr; 111(14):5343-8. PubMed ID: 24706814
[TBL] [Abstract][Full Text] [Related]
2. LRP5 variants may contribute to ADPKD.
Cnossen WR; te Morsche RH; Hoischen A; Gilissen C; Venselaar H; Mehdi S; Bergmann C; Losekoot M; Breuning MH; Peters DJ; Veltman JA; Drenth JP
Eur J Hum Genet; 2016 Feb; 24(2):237-42. PubMed ID: 25920554
[TBL] [Abstract][Full Text] [Related]
3. Liver cyst gene knockout in cholangiocytes inhibits cilium formation and Wnt signaling.
Wills ES; Te Morsche RHM; van Reeuwijk J; Horn N; Geomini I; van de Laarschot LFM; Mans DA; Ueffing M; Boldt K; Drenth JPH; Roepman R
Hum Mol Genet; 2017 Nov; 26(21):4190-4202. PubMed ID: 28973524
[TBL] [Abstract][Full Text] [Related]
4. Mutations in GANAB, Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease.
Porath B; Gainullin VG; Cornec-Le Gall E; Dillinger EK; Heyer CM; Hopp K; Edwards ME; Madsen CD; Mauritz SR; Banks CJ; Baheti S; Reddy B; Herrero JI; Bañales JM; Hogan MC; Tasic V; Watnick TJ; Chapman AB; Vigneau C; Lavainne F; Audrézet MP; Ferec C; Le Meur Y; Torres VE; ; ; Harris PC
Am J Hum Genet; 2016 Jun; 98(6):1193-1207. PubMed ID: 27259053
[TBL] [Abstract][Full Text] [Related]
5. Secondary, somatic mutations might promote cyst formation in patients with autosomal dominant polycystic liver disease.
Janssen MJ; Waanders E; Te Morsche RH; Xing R; Dijkman HB; Woudenberg J; Drenth JP
Gastroenterology; 2011 Dec; 141(6):2056-2063.e2. PubMed ID: 21856269
[TBL] [Abstract][Full Text] [Related]
6. A noncoding variant in GANAB explains isolated polycystic liver disease (PCLD) in a large family.
Besse W; Choi J; Ahram D; Mane S; Sanna-Cherchi S; Torres V; Somlo S
Hum Mutat; 2018 Mar; 39(3):378-382. PubMed ID: 29243290
[TBL] [Abstract][Full Text] [Related]
7. Isolated polycystic liver disease genes define effectors of polycystin-1 function.
Besse W; Dong K; Choi J; Punia S; Fedeles SV; Choi M; Gallagher AR; Huang EB; Gulati A; Knight J; Mane S; Tahvanainen E; Tahvanainen P; Sanna-Cherchi S; Lifton RP; Watnick T; Pei YP; Torres VE; Somlo S
J Clin Invest; 2017 May; 127(5):1772-1785. PubMed ID: 28375157
[TBL] [Abstract][Full Text] [Related]
8. Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing.
Lanktree MB; Haghighi A; Guiard E; Iliuta IA; Song X; Harris PC; Paterson AD; Pei Y
J Am Soc Nephrol; 2018 Oct; 29(10):2593-2600. PubMed ID: 30135240
[TBL] [Abstract][Full Text] [Related]
9. Somatic second-hit mutations leads to polycystic liver diseases.
Banales JM; Munoz-Garrido P; Bujanda L
World J Gastroenterol; 2013 Jan; 19(1):141-3. PubMed ID: 23326178
[TBL] [Abstract][Full Text] [Related]
10. Autophagy-mediated reduction of miR-345 contributes to hepatic cystogenesis in polycystic liver disease.
Masyuk T; Masyuk A; Trussoni C; Howard B; Ding J; Huang B; LaRusso N
JHEP Rep; 2021 Oct; 3(5):100345. PubMed ID: 34568801
[TBL] [Abstract][Full Text] [Related]
11. Genetics and mechanisms of hepatic cystogenesis.
van de Laarschot LFM; Drenth JPH
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1491-1497. PubMed ID: 28782656
[TBL] [Abstract][Full Text] [Related]
12. New explanation for autosomal dominant high bone mass: Mutation of low-density lipoprotein receptor-related protein 6.
Whyte MP; McAlister WH; Zhang F; Bijanki VN; Nenninger A; Gottesman GS; Lin EL; Huskey M; Duan S; Dahir K; Mumm S
Bone; 2019 Oct; 127():228-243. PubMed ID: 31085352
[TBL] [Abstract][Full Text] [Related]
13. Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease.
Waanders E; te Morsche RH; de Man RA; Jansen JB; Drenth JP
Hum Mutat; 2006 Aug; 27(8):830. PubMed ID: 16835903
[TBL] [Abstract][Full Text] [Related]
14. Heterozygosity of ALG9 in Association with Autosomal Dominant Polycystic Liver Disease.
Boerrigter MM; Duijzer R; Te Morsche RHM; Drenth JPH
Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761895
[TBL] [Abstract][Full Text] [Related]
15. Polycystic liver disease: ductal plate malformation and the primary cilium.
Wills ES; Roepman R; Drenth JP
Trends Mol Med; 2014 May; 20(5):261-70. PubMed ID: 24506938
[TBL] [Abstract][Full Text] [Related]
16. Chromosomal abnormalities in hepatic cysts point to novel polycystic liver disease genes.
Wills ES; Cnossen WR; Veltman JA; Woestenenk R; Steehouwer M; Salomon J; Te Morsche RH; Huch M; Hehir-Kwa JY; Banning MJ; Pfundt R; Roepman R; Hoischen A; Drenth JP
Eur J Hum Genet; 2016 Dec; 24(12):1707-1714. PubMed ID: 27552964
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity is present in SEC63 germline carriers with polycystic liver disease.
Janssen MJ; Salomon J; Te Morsche RH; Drenth JP
PLoS One; 2012; 7(11):e50324. PubMed ID: 23209713
[TBL] [Abstract][Full Text] [Related]
18. Clinical manifestation, epidemiology, genetic basis, potential molecular targets, and current treatment of polycystic liver disease.
Mahboobipour AA; Ala M; Safdari Lord J; Yaghoobi A
Orphanet J Rare Dis; 2024 Apr; 19(1):175. PubMed ID: 38671465
[TBL] [Abstract][Full Text] [Related]
19. Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity.
Korvala J; Jüppner H; Mäkitie O; Sochett E; Schnabel D; Mora S; Bartels CF; Warman ML; Deraska D; Cole WG; Hartikka H; Ala-Kokko L; Männikkö M
BMC Med Genet; 2012 Apr; 13():26. PubMed ID: 22487062
[TBL] [Abstract][Full Text] [Related]
20. Abnormal hepatocystin caused by truncating PRKCSH mutations leads to autosomal dominant polycystic liver disease.
Drenth JP; Tahvanainen E; te Morsche RH; Tahvanainen P; Kääriäinen H; Höckerstedt K; van de Kamp JM; Breuning MH; Jansen JB
Hepatology; 2004 Apr; 39(4):924-31. PubMed ID: 15057895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
